Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Roctavian Market Report 2025

Roctavian Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Clinical Indication (Severe Hemophilia A, Prophylactic Therapy, Patients Without Factor VIII Inhibitors, Patients With Neutralizing Antibodies To AAV5), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Specialty Clinics, Homecare Providers, Research Institutions)

Roctavian Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Roctavian Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Roctavian Market Definition

Roctavian is a gene therapy developed to treat hemophilia A, a genetic disorder caused by a deficiency in clotting factor VIII. The treatment delivers a functional copy of the factor VIII gene, enabling the body to produce the clotting factor naturally. It offers the potential for long-term or permanent relief from the condition.

The main clinical indications of roctavian are severe hemophilia A, prophylactic therapy, patients without factor VIII inhibitors, and patients with neutralizing antibodies to AAV5. Severe hemophilia A refers to a genetic disorder in which a person has very low levels or an absence of clotting factor VIII, which is essential for blood clotting. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to various end users, including hospitals, specialty clinics, homecare providers, and research institutions.

Roctavian Market Segmentation

The roctavian market covered in this report is segmented –

1) By Clinical Indication: Severe Hemophilia A; Prophylactic Therapy; Patients Without Factor VIII Inhibitors; Patients With Neutralizing Antibodies To AAV5

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Hospitals; Specialty Clinics; Homecare Providers; Research Institutions

Roctavian Market Size and growth rate 2025 to 2029: Graph

Roctavian Market Size 2025 And Growth Rate

The roctavian market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing awareness and early diagnosis, increasing half-life of factor VIII, increasing awareness and better diagnostic tools, increasing research and development efforts, and increasing awareness of uncommon diseases.

Roctavian Market Growth Forecast

The roctavian market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing focus on developing advanced therapies, increasing gene therapy's success rates, increasing propensity for preventive treatment, increasing the number of disease therapeutics, and growing prevalence of genetic disorders. Major trends in the forecast period include innovative treatments and therapies, technological advancements, FDA approvals, novel therapeutic products, and clinical trials and regulatory approvals.

Book your 30 minutes free consultation with our research experts

Contact Us

Roctavian Market Driver: Rising Prevalence Of Hemophilia Driving Growth In The Market

The increase in the prevalence of hemophilia is expected to propel the growth of the roctavian market going forward. Hemophilia is a genetic disorder causing improper blood clotting due to a deficiency in clotting factors, typically treated with replacement therapy. The prevalence of hemophilia is increasing due to improved diagnosis, awareness, and genetic testing identifying more cases. Roctavian is used to treat hemophilia A by providing a one-time gene therapy infusion that enables the body to produce its own Factor VIII, reducing bleeding episodes and the need for regular clotting factor treatments. For instance, in October 2022, according to a report published by the World Federation of Hemophilia Report, a Canada-based non-profit organization, in 2022, 427,685 individuals worldwide were diagnosed with bleeding disorders. This included 257,146 cases of hemophilia (208,957 of hemophilia A, 42,203 of hemophilia B, and 5,986 with an unspecified type), 100,505 cases of von Willebrand disease, and 70,034 cases of other bleeding disorders. Therefore, the increase in the prevalence of hemophilia is driving the growth of the roctavian market.

Roctavian Market Driver: Rising Healthcare Investments Fueling Growth In The Market

The rising healthcare investments are expected to fuel the growth of the roctavian market going forward. Healthcare investments involve allocating capital into healthcare-related sectors, such as pharmaceuticals, medical devices, and digital health, to support growth and innovation. Increasing healthcare investments are driven by rising demand due to aging populations, technological advancements, and growing chronic diseases. Healthcare investments in roctavian are used to support its research, clinical trials, regulatory approvals, manufacturing, and market access strategies to ensure widespread availability and effective treatment. For instance, in May 2023, according to the Office for National Statistics, a UK-based organization, healthcare expenditure in the UK totaled around $354.88 billion (£283 billion) in 2022, marking a nominal increase of 0.7% compared to the previous year’s spending in 2021. Therefore, the rising healthcare investments are driving the growth of the Roctavian market.

Global Roctavian Market Major Players

Major companies operating in the roctavian market are BioMarin Pharmaceutical Inc.

Global Roctavian Market Trend: Regulatory Approvals Driving Market Expansion

The key trend in the roctavian market is securing regulatory approvals to extend its reach across regions and patient groups, enabling wider access to this cutting-edge gene therapy. Regulatory approvals signify authorization from health authorities to market and distribute medical products after verifying their safety, efficacy, and quality. For instance, in June 2023, BioMarin Pharmaceutical Inc., a US-based biotechnology company, received approval from the U.S. Food and Drug Administration (FDA) for Roctavian, the first and only gene therapy for adults with severe hemophilia A. This innovative treatment aims to enable patients to produce their own Factor VIII, which significantly reduces bleeding episodes and the need for regular infusions. The approval was based on data from the GENEr8-1 clinical trial, which demonstrated the therapy's effectiveness in decreasing bleeding rates. With an estimated 2,500 eligible adults in the U.S., this groundbreaking therapy marks a major advancement in the treatment of hemophilia A, offering new hope for improved patient outcomes.

Regional Analysis For The Global Roctavian Market

North America was the largest region in the roctavian market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roctavian market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the roctavian market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Roctavian Market?

The roctavian market consists of sales of coagulation factor VIII products, immunosuppressive medications, and recombinant factor IX products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Roctavian Industry?

The roctavian market research report is one of a series of new reports from The Business Research Company that provides roctavian market statistics, including roctavian industry global market size, regional shares, competitors with a roctavian market share, detailed roctavian market segments, market trends and opportunities, and any further data you may need to thrive in the roctavian industry. This roctavian market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

    Table Of Contents

    1. Executive Summary

    2. Roctavian Market Characteristics

    3. Roctavian Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Roctavian Market Trends And Strategies

    5. Roctavian Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Roctavian Growth Analysis And Strategic Analysis Framework

    6.1. Global Roctavian PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Roctavian Market Growth Rate Analysis

    6.4. Global Roctavian Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Roctavian Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Roctavian Total Addressable Market (TAM)

    7. Global Roctavian Pricing Analysis & Forecasts

    8. Roctavian Market Segmentation

    8.1. Global Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Severe Hemophilia A

    Prophylactic Therapy

    Patients Without Factor VIII Inhibitors

    Patients With Neutralizing Antibodies To AAV5

    8.2. Global Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    8.3. Global Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Clinics

    Homecare Providers

    Research Institutions

    9. Global Roctavian Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Roctavian Market Regional And Country Analysis

    10.1. Global Roctavian Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Roctavian Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Roctavian Market

    11.1. Asia-Pacific Roctavian Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Roctavian Market

    12.1. China Roctavian Market Overview

    12.2. China Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Roctavian Market

    13.1. India Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Roctavian Market

    14.1. Japan Roctavian Market Overview

    14.2. Japan Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Roctavian Market

    15.1. Australia Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Roctavian Market

    16.1. South Korea Roctavian Market Overview

    16.2. South Korea Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Roctavian Market

    17.1. Western Europe Roctavian Market Overview

    17.2. Western Europe Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Roctavian Market

    18.1. UK Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Roctavian Market

    19.1. Germany Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Roctavian Market

    20.1. France Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Roctavian Market

    21.1. Eastern Europe Roctavian Market Overview

    21.2. Eastern Europe Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Roctavian Market

    22.1. North America Roctavian Market Overview

    22.2. North America Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Roctavian Market

    23.1. USA Roctavian Market Overview

    23.2. USA Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Roctavian Market

    24.1. Canada Roctavian Market Overview

    24.2. Canada Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Roctavian Market

    25.1. South America Roctavian Market Overview

    25.2. South America Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Roctavian Market

    26.1. Middle East Roctavian Market Overview

    26.2. Middle East Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Roctavian Market

    27.1. Africa Roctavian Market Overview

    27.2. Africa Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Roctavian Market Competitive Landscape And Company Profiles

    28.1. Roctavian Market Competitive Landscape

    28.2. Roctavian Market Company Profiles

    28.2.1. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Roctavian Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Roctavian Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Roctavian Market

    32. Recent Developments In The Roctavian Market

    33. Roctavian Market High Potential Countries, Segments and Strategies

    33.1 Roctavian Market In 2029 - Countries Offering Most New Opportunities

    33.2 Roctavian Market In 2029 - Segments Offering Most New Opportunities

    33.3 Roctavian Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Roctavian Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Roctavian Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: BioMarin Pharmaceutical Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Roctavian Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Roctavian Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Roctavian Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Roctavian Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Roctavian Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: BioMarin Pharmaceutical Inc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

Factoring Market 2023 – By Type (Recourse, Non-Recourse), By Organization Size (Small And Medium Enterprises, Large Enterprises), By Category (International, Domestic), By Application (Transportation, Healthcare, Construction, Manufacturing, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Antivirus Software Global Market Report 2025 – By Type (Computers, Tablets, Smart Phones, Other Types), By Operating System (Windows, MAC, Android Or IOS Or Linux), By End User (Corporate, Personal, Government) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Safety Services Global Market Report 2025 – By Services (ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies, Other services ), By Phase (Phase 1, Phase 2, Phase 3), By End User (Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plant-Based Vaccines Global Market Report 2025 – By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types), By Source (Tobacco Plant, Maize, Potato, Other Sources), By Application (Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Preclinical Assets Global Market Report 2025 – By Service (Bioanalysis And DMPK (Drug Metabolism and Pharmacokinetic) studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services), By Model Type (Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model), By End User (Biopharmaceutical Companies, Government Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Roctavian market?

Roctavian is a gene therapy developed to treat hemophilia A, a genetic disorder caused by a deficiency in clotting factor VIII. The treatment delivers a functional copy of the factor VIII gene, enabling the body to produce the clotting factor naturally. It offers the potential for long-term or permanent relief from the condition. For further insights on the Roctavian market, request a sample here

How will the Roctavian market drivers and restraints affect the market dynamics? What forces will shape the Roctavian industry going forward?

The Roctavian market major growth driver - Rising Prevalence Of Hemophilia Driving Growth In The Market. For further insights on the Roctavian market, request a sample here

What is the forecast market size or the forecast market value of the Roctavian market?

The Roctavian market size has grown strongly in recent years. The roctavian market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing awareness and early diagnosis, increasing half-life of factor VIII, increasing awareness and better diagnostic tools, increasing research and development efforts, and increasing awareness of uncommon diseases. The roctavian market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing focus on developing advanced therapies, increasing gene therapy's success rates, increasing propensity for preventive treatment, increasing the number of disease therapeutics, and growing prevalence of genetic disorders. Major trends in the forecast period include innovative treatments and therapies, technological advancements, FDA approvals, novel therapeutic products, and clinical trials and regulatory approvals. For further insights on the Roctavian market, request a sample here

How is the Roctavian market segmented?

The roctavian market covered in this report is segmented –
1) By Clinical Indication: Severe Hemophilia A; Prophylactic Therapy; Patients Without Factor VIII Inhibitors; Patients With Neutralizing Antibodies To AAV5
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End User: Hospitals; Specialty Clinics; Homecare Providers; Research Institutions For further insights on the Roctavian market, request a sample here

Which region has the largest share of the Roctavian market? What are the other regions covered in the report?

North America was the largest region in the roctavian market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roctavian market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Roctavian market, request a sample here.

Who are the major players in the Roctavian market?

Major companies operating in the roctavian market are BioMarin Pharmaceutical Inc. . For further insights on the Roctavian market, request a sample here.

What are the key trends in the Roctavian market?

Major trends in the Roctavian market include Regulatory Approvals Driving Market Expansion. For further insights on the Roctavian market, request a sample here.

What are the major opportunities in the Roctavian market? What are the strategies for the Roctavian market?

For detailed insights on the major opportunities and strategies in the Roctavian market, request a sample here.

How does the Roctavian market relate to the overall economy and other similar markets?

For detailed insights on Roctavian's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Roctavian industry?

For detailed insights on the mergers and acquisitions in the Roctavian industry, request a sample here.

What are the key dynamics influencing the Roctavian market growth? SWOT analysis of the Roctavian market.

For detailed insights on the key dynamics influencing the Roctavian market growth and SWOT analysis of the Roctavian industry, request a sample here.